相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab: A Review of Its Use in Advanced Cancer
Gillian M. Keating
DRUGS (2014)
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer
Prasanth Ganesan et al.
INVESTIGATIONAL NEW DRUGS (2014)
Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer
Prasanth Ganesan et al.
INVESTIGATIONAL NEW DRUGS (2013)
Lenalidomide in solid tumors
Angela Segler et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Results of a Multicenter, Randomized, Double-Blind, Dose-Evaluating Phase 2/3 Study of Lenalidomide in the Treatment of Metastatic Malignant Melanoma
John Glaspy et al.
CANCER (2009)
Phase II study of lenalidomide in patients with metastatic renal cell carcinoma
Toni K. Choueiri et al.
CANCER (2006)
Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response
Vladimir Gotlib et al.
ANTI-CANCER DRUGS (2006)
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies
R. A. Sharma et al.
EUROPEAN JOURNAL OF CANCER (2006)
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
SV Rajkumar et al.
BLOOD (2005)
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro
K Dredge et al.
MICROVASCULAR RESEARCH (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
